MARINER - Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk

26 August 2018 (14:32 - 14:42)
Organised by:
Congress Presentation Part of: Hot Line Session 1 Prevention ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by